Obstetric Management in Maternal with Covid-19

2021 ◽  
Vol 1 (6) ◽  
pp. 130-134
Author(s):  
Asoly Giovano
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Pregnant Women ◽  
Respiratory Disease ◽  
Short Duration ◽  
Cellular Immunity ◽  
Severe Pneumonia ◽  
Physiological Changes ◽  
The World ◽  
Obstetric Management

Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS- CoV-2). Covid-19 pandemic began in the end of 2019 and spread all over the world in a short duration of time. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 can lead to severe contagious respiratory disease. Due to impaired cellular immunity and physiological changes, pregnant women are susceptible to respiratory disease and are more likely to develop severe pneumonia.  

scholarly journals Obstetric Management in Maternal with Covid-19

2021 ◽  
Vol 1 (6) ◽  
pp. 130-134
Author(s):  
Asoly Giovano
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Pregnant Women ◽  
Respiratory Disease ◽  
Short Duration ◽  
Cellular Immunity ◽  
Severe Pneumonia ◽  
Physiological Changes ◽  
The World ◽  
Obstetric Management

Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS- CoV-2). Covid-19 pandemic began in the end of 2019 and spread all over the world in a short duration of time. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 can lead to severe contagious respiratory disease. Due to impaired cellular immunity and physiological changes, pregnant women are susceptible to respiratory disease and are more likely to develop severe pneumonia.

scholarly journals Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus

2020 ◽  
Vol 41 (04) ◽  
pp. 568-578 ◽  
Author(s):  
Jaffar A. Al-Tawfiq ◽  
Ziad A. Memish
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Emerging Infectious Diseases ◽  
Case Fatality ◽  
Severe Pneumonia ◽  
Middle East Respiratory Syndrome ◽  
Zoonotic Pathogen ◽  
Clinical Presentations ◽  
The World ◽  
Novel Coronavirus

AbstractEmerging infectious diseases continue to be of a significant importance worldwide with the potential to cause major outbreaks and global pandemics. In 2002, the world had witnessed the appearance of the severe acute respiratory syndrome coronavirus in China which disappeared abruptly within 6 months. About a decade later, a new and emerging novel coronavirus named the Middle East respiratory syndrome coronavirus (MERS-CoV) was described in a patient from Saudi Arabia. These two coronaviruses shared multiple similarities in the epidemiology, clinical presentations, and posed challenges in its prevention and management. Seven years since its discovery, MERS-CoV continues to be a lethal zoonotic pathogen capable of causing severe pneumonia with high case fatality rates and the ability to cause large health care-associated outbreaks.

Plasma therapy a possible hope to fight against COVID-19

2020 ◽  
Author(s):  
Ravikant Piyush ◽  
Aroni Chatterjee ◽  
Shashikant Ray
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Viral Disease ◽  
Plasma Therapy ◽  
Therapeutic Drugs ◽  
Wild Fire ◽  
The World ◽  
Short Span ◽  
Game Changer

The world is currently going through a disastrous event and a catastrophic upheaval caused by the coronavirus disease 2019 (COVID-19). The pandemic has resulted in loss of more than 150000 deaths across the globe. Originating from China and spreading across all continents within a short span of time, it has become a matter of international emergency. Different agencies are adopting diverse approaches to stop and spread of this viral disease but still now nothing confirmatory has come up. Due to lack of vaccines and proper therapeutic drugs, the disease is still spreading like wild fire without control. An Old but very promising method- the convalescent plasma therapy could be the key therapy to stop this pandemic. This method has already proven its mettle on several occasions previously and has been found to be effective in curing the pandemics induced by Ebola, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the same group of β-Coronavirus that has resulted in the above diseases. Therefore, the role of plasma therapy is being explored for treatment of this disease. In this review, we have mainly focused on the role of convalescent plasma therapy and why its use should be promoted in fight against COVID-19, as it could turn out to be a game changer.

scholarly journals PREGNANCY CARE IN COVID19 THROUGH AYURVEDA

2021 ◽  
Vol p6 (1) ◽  
pp. 3219-3222
Author(s):  
Mrityunjoy Baroi ◽  
Dipak Kr. Goswami
Keyword(s):  
Infectious Disease ◽  
Pregnant Women ◽  
Adverse Outcomes ◽  
Physiological Changes ◽  
Vulnerable Group ◽  
Pregnancy Care ◽  
Preg Nancy ◽  
The World ◽  
Systemic Manifestations ◽  
Maternal Wellbeing

The coronavirus disease 2019 (COVID-19) is a highly transmittable and pathogenic viral infection caused by se- vere acute respiratory syndrome coronavirus 2 (SARS COV-2) and Garbha-Kala is one of the most crucial and responsible stages in women's life. COVID-19 can produce a devastating effect on maternal wellbeing. Ayurveda has mentioned the pandemic situation under the term Janapadodhwamsa which spread through Vayu, Jala, Desha and Kala. The outbreak of Covid-19 is severely affecting the world. It is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. It has mainly respiratory and systemic manifestations. People having diabetes, chronic diseases, pregnant women are more prone to this infection as they are more susceptible to path- ogens and the development of severe conditions like pneumonia. Due to the physiological changes during preg- nancy, pregnant women are the most vulnerable group in this pandemic situation because infection during preg- nancy can result in adverse outcomes. Much research is still in continuation because we are not sure of much evi- dence till now. Many preventive protocols suggested by Ayurveda can prevent the prevalence of disease up to some extent. Keywords: Ayurveda, Covid-19, Janapadodhwamsa, Pandemic, Pregnancy

scholarly journals Does the novel coronavirus 2019 like heart more than the other family members of coronaviruses?

2020 ◽  
Vol 12 (2) ◽  
pp. 156-157
Author(s):  
Mohammad Mostafa Ansari Ramandi ◽  
Mohammadreza Baay ◽  
Nasim Naderi
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Family Members ◽  
Middle East Respiratory Syndrome ◽  
The Other ◽  
The Novel ◽  
The World ◽  
Future Challenges ◽  
Novel Coronavirus ◽  
Coronavirus Infections

The disaster due to the novel coronavirus disease 2019 (COVID-19) around the world has made investigators enthusiastic about working on different aspects of COVID-19. However, although the pandemic of COVID-19 has not yet ended, it seems that COVID-19 compared to the other coronavirus infections (the Middle East Respiratory Syndrome [MERS] and Severe Acute Respiratory Syndrome [SARS]) is more likely to target the heart. Comparing the previous presentations of the coronavirus family and the recent cardiovascular manifestations of COVID-19 can also help in predicting possible future challenges and taking measures to tackle these issues.

scholarly journals Coronavirus: Penyakit Lama, Virus Lama, Kemasan Baru

2020 ◽  
Vol 2 (1) ◽  
pp. 43
Author(s):  
Heru Wijono
Keyword(s):  
Middle East ◽  
Incubation Period ◽  
Respiratory Disease ◽  
Virus Strain ◽  
Severe Pneumonia ◽  
Middle East Respiratory Syndrome ◽  
Advanced Age ◽  
Acute Respiratory Disease

Abstract— Covid -19, a virus strain and a member of family with known member as Severe Acute Respiratory Disease (SARS) or Middle East Respiratory Syndrome (MERS), but having a potentially lethal differences in not readily recognized by our immunity. Classified as betacoronavirus, with incubation period up to 14 days, the sign and symptoms can be highly variable, from asymptomatic to mild to criticalin the form of severe pneumonia. Almost half the persons infected did not show any symptoms, but in cases of people with comorbidities such as advanced age, pregnancy, obesity or other certain diseases, could increase the likelihood of morbidity and even potentially fatal. Covid-19 has spread globally, including Indonesia, with a potentially increased number of cases, prevention in covid-19 protocol is a necessity. Keywords: Covid-19, SARS, symptoms, variable, prevention Abstrak— Covid-19, yang sebelumnya dikenal sebagai virus strain dari kelompok family yang sama dengan Severe Acute Respiratory Disease (SARS) atau Middle East Respiratory Syndrome (MERS), tapi memiliki fatalitas yang secara potensial lebih tinggi, karena bersiafat novel bagi sistem imunitas kita. Termasuk betacoronavirus, dengan masa inkubasi sampai dengan 14 hari, tanda dan gejala penyakit bisa sangat bervariasi, mulai dari asimtomatik, ringan sampai berat, dalam bentuk pneumonia berat. Hamper separuh penderita yang terinfeksi tidak menunjukkan gejala sama sekali, tapi pada penderita dengan komorbiditas seperti usia lanjut, kehamilan, obesitas atau penyakit kronis tertentu, resiko moribiditas dan mortalitas dapat meningkat. Covid-19 saat ini sudah menyebar ke seluruh dunia, termasuk Indonesia, dengan adanya potensi kenaikan kasus lebih banyak, pencegahan dalam bentuk protocol covid-19 bersifat mutlak diperlukan. Kata kunci: Covid-19, SARS, gejala, bervariasi, pencegahan

scholarly journals Infections in Pregnancy With COVID-19 and Other Respiratory RNA Virus Diseases Are Rarely, If Ever, Transmitted to the Fetus: Experiences With Coronaviruses, Parainfluenza, Metapneumovirus Respiratory Syncytial Virus, and Influenza

2020 ◽  
Vol 144 (8) ◽  
pp. 920-928 ◽  
Author(s):  
David A. Schwartz ◽  
Amareen Dhaliwal
Keyword(s):  
Respiratory Syncytial Virus ◽  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Pregnant Women ◽  
Rna Viruses ◽  
Middle East Respiratory Syndrome ◽  
Intrauterine Transmission ◽  
Fetal Infection ◽  
Syncytial Virus ◽  
Maternal Fetal Transmission

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent of coronavirus disease 2019 (COVID-19), is similar to 2 other coronaviruses, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), in causing life-threatening maternal respiratory infections and systemic complications. Because of global concern for potential intrauterine transmission of SARS-CoV-2 from pregnant women to their infants, this report analyzes the effects on pregnancy of infections caused by SARS-CoV-2 and other respiratory RNA viruses, and examines the frequency of maternal-fetal transmission with SARS-CoV-2, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, respiratory syncytial virus (RSV), parainfluenza (HPIV), and metapneumovirus (hMPV). There have been no confirmed cases of intrauterine transmission reported with SARS-CoV-2 or any other coronaviruses—SARS and MERS. Influenza virus, despite causing approximately 1 billion annual infections globally, has only a few cases of confirmed or suspected intrauterine fetal infections reported. Respiratory syncytial virus is an unusual cause of illness among pregnant women, and with the exception of 1 premature infant with congenital pneumonia, no other cases of maternal-fetal infection are described. Parainfluenza virus and hMPV can produce symptomatic maternal infections but do not cause intrauterine fetal infection. In summary, it appears that the absence thus far of maternal-fetal transmission of the SARS-CoV-2 virus during the COVID-19 pandemic is similar to other coronaviruses, and is also consistent with the extreme rarity of suggested or confirmed cases of intrauterine transmission of other respiratory RNA viruses. This observation has important consequences for pregnant women because it appears that if intrauterine transmission of SARS-CoV-2 does eventually occur, it will be a rare event. Potential mechanisms of fetal protection from maternal viral infections are also discussed.

scholarly journals Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnant Women and Their Infants

2020 ◽  
Vol 144 (10) ◽  
pp. 1217-1222 ◽  
Author(s):  
Hui Yang ◽  
Bin Hu ◽  
Sudong Zhan ◽  
Li-ye Yang ◽  
Guoping Xiong
Keyword(s):  
Computed Tomography ◽  
Severe Acute Respiratory Syndrome ◽  
Pregnant Women ◽  
Perinatal Death ◽  
Severe Pneumonia ◽  
Neonatal Morbidity ◽  
Late Pregnancy ◽  
Chest Computed Tomography ◽  
Polymerase Chain ◽  
Novel Coronavirus

Context.— The pandemic of a novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created an unprecedented global health burden. Objective.— To investigate the effect of the SARS-CoV-2 infection on maternal, fetal, and neonatal morbidity and other poor obstetrical outcomes. Design.— All suspected cases of pregnant women with coronavirus disease 2019 (COVID-19) admitted into one center in Wuhan from January 20 to March 19, 2020, were included. Detailed clinical data of those pregnancies with COVID-19 were retrospectively collected and analyzed. Results.— Twenty-seven pregnant women (4 early pregnancies included) with laboratory or clinically confirmed SARS-CoV-2 infection and 24 neonates born to the 23 women in late pregnancy were analyzed. On admission, 46.2% (13 of 27) of the patients had symptoms, including fever (11 of 27), cough (9 of 27), and vomiting (1 of 27). Decreased total lymphocytes count was observed in 81.5% (22 of 27) of patients. Twenty-six patients showed typical viral pneumonia by chest computed tomography scan, whereas 1 patient confirmed with COVID-19 infection showed no abnormality on chest computed tomography. One mother developed severe pneumonia 3 days after her delivery. No maternal or perinatal death occurred. Moreover, 1 early preterm newborn born to a mother with the complication of premature rupture of fetal membranes, highly suspected to have SARS-CoV-2 infection, was SARS-CoV-2 negative after repeated real-time reverse transcriptase polymerase chain reaction testing. Statistical differences were observed between the groups of women in early and late pregnancy with COVID-19 in the occurrence of lymphopenia and thrombocytopenia. Conclusions.— No major complications were reported among the studied cohort, though 1 serious case and 1 perinatal infection were observed. Much effort should be made to reduce the pathogenic effect of COVID-19 infection in pregnancies.

scholarly journals Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?

Biomolecules ◽  
2020 ◽  
Vol 10 (9) ◽  
pp. 1312 ◽  
Author(s):  
Fatma Elrashdy ◽  
Elrashdy M. Redwan ◽  
Vladimir N. Uversky
Keyword(s):  
Middle East ◽  
Environmental Factors ◽  
Severe Acute Respiratory Syndrome ◽  
Human Population ◽  
Viral Transmission ◽  
Host Factors ◽  
The Past ◽  
Viral Structure ◽  
The World ◽  
Human Host Factors

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a pandemic of coronavirus disease 2019 (COVID-19). The worldwide transmission of COVID-19 from human to human is spreading like wildfire, affecting almost every country in the world. In the past 100 years, the globe did not face a microbial pandemic similar in scale to COVID-19. Taken together, both previous outbreaks of other members of the coronavirus family (severe acute respiratory syndrome (SARS-CoV) and middle east respiratory syndrome (MERS-CoV)) did not produce even 1% of the global harm already inflicted by COVID-19. There are also four other CoVs capable of infecting humans (HCoVs), which circulate continuously in the human population, but their phenotypes are generally mild, and these HCoVs received relatively little attention. These dramatic differences between infection with HCoVs, SARS-CoV, MERS-CoV, and SARS-CoV-2 raise many questions, such as: Why is COVID-19 transmitted so quickly? Is it due to some specific features of the viral structure? Are there some specific human (host) factors? Are there some environmental factors? The aim of this review is to collect and concisely summarize the possible and logical answers to these questions.

scholarly journals Covid-19: The Wuhan Pandemic

2020 ◽  
Vol 10 (3) ◽  
pp. 251-253
Author(s):  
Tooba Masood
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Large Family ◽  
Respiratory Illness ◽  
Middle East Respiratory Syndrome ◽  
Human Beings ◽  
The World ◽  
Novel Virus ◽  
Prevention Guidelines

Coronavirus belongs to a large family of viruses that usually cause respiratory illness in human beings that can be mild and severe depending upon the strain. In 2002, the outbreak of SARS (severe acute respiratory syndrome) reported more than 8000 infected cases with 774 mortalities. In 2012, the outbreak of MERS (middle east respiratory syndrome) infected around 2494 people and 858 deaths were reported according to the WHO. In January 2020, a new strain of coronavirus named 2019-nCoV has been identified in China. The number of confirmed cases has been increasing reaching 5,593,631 cases worldwide with 353,334 deaths up till 28th May 2020 according to WHO situation report-129. Concerned authorities are working on minimizing its spread. Prevention guidelines have been released by WHO, hoping to control the transmission and save the world from the effects of this novel virus.

Sign in / Sign up

Export Citation Format

Share Document